-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Outperform on Cardinal Health, Lowers Price Target to $186

Benzinga·08/12/2025 22:05:22
Listen to the news
Leerink Partners analyst Michael Cherny maintains Cardinal Health (NYSE:CAH) with a Outperform and lowers the price target from $188 to $186.